Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism

NCT03941236 · clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
42
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Zealand Pharma